Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients With Hairy Cell Leukemia

NCT06965114 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

84

Enrollment

NIH

Sponsor class

Conditions

Hairy Cell Leukemia
Recurrent Hairy Cell Leukemia
Refractory Hairy Cell Leukemia

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
DRUG: Cladribine
PROCEDURE: Computed Tomography
BIOLOGICAL: Rituximab
DRUG: Tovorafenib

Sponsor

National Cancer Institute (NCI)